Thanks to robust skills and investment in R&D, Korea is leading in the development of frontier technologies with potential to transform production processes, stimulate the entry of new firms, and the launch of ground-breaking products and applications, according to a new OECD report.
The internationally recognised methodology for collecting and using R&D statistics, the OECD's Frascati Manual is an essential tool for statisticians and science and innovation policy makers worldwide. It includes definitions of basic concepts, data collection guidelines, and classifications for compiling R&D statistics. This updated edition contains improved guidelines reflecting recent changes in the way R&D takes place and is funded and the wider use of R&D statistics and definitions. It provides new chapters dedicated to the pratical aspects of collecting R&D data in different sectors, as well as new guidance on capturing different aspects of public support for R&D such as tax incentives.
OECD major events and activities relating to biotechnologies: latest developments are updated biannually in this Newsletter.
Today the OECD marks the end of a seven year experimental testing programme, investigating 11 commercially viable nanomaterials across 110 chemical tests. The results were co-ordinated across 11 countries with tests and data generated from government agencies, universities, research institutions and businesses. Over 780 studies on the specific properties of nanomaterials were undertaken.
The OECD’s Annual Meeting at Ministerial Level reinforced member governments’ support across a broad range of key OECD work.
Innovation and creativity have long been hallmarks of the Czech Republic. After all, this is the country that invented the term “robot”, when Czech writer, Karel Čapek, coined the word back in 1921.
Dementia is increasing in prevalence, and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research. Further, moving beyond established medical data into big data offers the potential to tap into routinely collected data from both within and outside the health system.
This project has reviewed how current measurement frameworks capture the broad range of innovation activities in firms, and in particular how design activities are reflected. It highlights which concepts, definitions and measurement approaches can be used to produce policy-relevant indicators on the role of design in innovation.
Squeezed R&D budgets in the EU, Japan and US are reducing the weight of advanced economies in science and technology research, patent applications and scientific publications and leaving China on track to be the world’s top R&D spender by around 2019, according to a new OECD report.
Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.